First Shot Therapy Completes Series A Funding

First Aid Shot Therapy ("F.A.S.T.") said on Wednesday that it has completed a Series A financing round. No financial terms were disclosed. Sofinnova Ventures led the round. According to F.A.S.T., the funds will be used for the company's U.S. product launch beginning this summer. F.A.S.T, which is headquartered in Burlingame, Calif., is a consumer healthcare company focused on over-the-counter therapies in liquid form.

North AmericaUSBriefs